首页> 外文期刊>Biomacromolecules >Understanding the Coacervate-to-Vesicle Transition of Globular Fusion Proteins to Engineer Protein Vesicle Size and Membrane Heterogeneity
【24h】

Understanding the Coacervate-to-Vesicle Transition of Globular Fusion Proteins to Engineer Protein Vesicle Size and Membrane Heterogeneity

机译:了解球状融合蛋白的凝固到囊泡转变为工程师蛋白囊泡尺寸和膜异质性

获取原文
获取原文并翻译 | 示例
       

摘要

Protein-rich coacervates are liquid phases separate from the aqueous bulk phase that are used by nature for compartmentalization and more recently have been exploited by engineers for delivery and formulation applications. They also serve as an intermediate phase in an assembly path to more complex structures, such as vesicles. Recombinant fusion protein complexes made from a globular protein fused with a glutamic acid-rich leucine zipper (globule-Z(E)) and an arginine-rich leucine zipper fused with an elastin-like polypeptide (Z(R)-ELP) show different phases from soluble, through an intermediate coacervate phase, and finally to vesicles with increasing temperature of the aqueous solution. We investigated the phase transition kinetics of the fusion protein complexes at different temperatures using dynamic light scattering and microscopy, along with mathematical modeling. We controlled coacervate growth by aging the solution at an intermediate temperature that supports coacervation and confirmed that the size of the coacervate droplets dictates the size of vesicles formed upon further heating. With this understanding of the phase transition, we developed strategies to induce heterogeneity in the organization of globular proteins in the vesicle membrane through simple mixing of coacervates containing two different globular fusion proteins prior to the vesicle transition. This study gives fundamental insights and practical strategies for development of globular protein-rich coacervates and vesicles for drug delivery, microreactors, and protocell applications.
机译:富含蛋白质的凝聚率是与含水体阶段分开的液相,该液相由自然使用以进行舱室化,最近通过工程师利用更新用于输送和配方应用。它们还用作更复杂的结构的组装路径中的中间相位,例如囊泡。由与富含谷氨酸的亮氨酸拉链(Globule-Z(E))融合的球状蛋白质制成的重组融合蛋白复合物和与弹性蛋白的多肽(Z(R)-ELP)显示不同的精氨酸富亮氨酸拉链通过中间凝集相可以溶于溶于阶段,最后在水溶液温度增加的囊泡中。我们研究了使用动态光散射和显微镜的不同温度下的融合蛋白复合物的相转移动力学以及数学建模。通过在支撑凝集的中间温度下老化溶液来控制凝聚性生长,并确认凝聚液滴的尺寸决定在进一步加热时形成的囊泡的尺寸。通过这种了解相转移,我们通过在囊泡转变之前简单地混合含有两种不同的球状融合蛋白在囊泡膜中的球状蛋白组织中诱导异质性的策略。本研究为出汗蛋白质的富含凝聚层和囊泡进行了根本的见解和实际策略,用于药物递送,微吸管和Protocell应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号